Posts

Showing posts from February, 2022

Site management organizations (SMO) market is projected to grow at an annualized rate of ~10% during the period 2021-2035.

  In addition to being a time and cost intensive process, clinical trials are fraught with several challenges; considering the expertise available with site management organizations ( SMO s) to conduct such studies in an efficient manner, trial sponsors are actively outsourcing their requirements   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Site Management Organizations (SMO) Market, 2021–2035 .”   The study features an in-depth analysis, highlighting the capabilities of clinical trial site management service providers engaged in this domain. Amongst other elements, the report features: §   A detailed assessment of the current market landscape of companies offering clinical trial site management services.  §   A competitiveness analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW). The companies ...

The RNA targeting small molecules therapeutics market is estimated to be worth USD 8.3 billion in 2030.

  In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “ RNA Targeting Small Molecules Therapeutics Market ”   The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:   §   An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical stag...